-
Gilenya May Help Control Severe Respiratory Disease in COVID-19
A report details an RRMS patient on long-term Gilenya (fingolimod) use, who developed severe COVID-19 infection with lung involvement and recovered well. Read the full story here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.